BackClene- Warrants (30/12/2025) Overview

Clene- Warrants (30/12/2025) Accounts Payable

Latest accounts payable for CLNNW: $1.1M.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.14M
37.92% YoYΔ $314000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Clene- Warrants (30/12/2025) Accounts Payable History

Loading

Clene- Warrants (30/12/2025) vs. peers: Accounts Payable Comparison

Loading

Clene- Warrants (30/12/2025) Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Clene- Warrants (30/12/2025) (CLNNW) FAQ

The latest accounts payable for CLNNW is $1.1M as of June 2026. That compares with $830K in the prior-year period — up 37.9% year over year. Investors often review this figure alongside Clene- Warrants (30/12/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, CLNNW's accounts payable moved from $830K to $1.1M — a 37.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Clene- Warrants (30/12/2025)'s operating scale or balance-sheet position.

A accounts payable figure of $1.1M for CLNNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CLNNW's accounts payable ($1.1M), review year-over-year change from $830K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Clene- Warrants (30/12/2025)'s accounts payable against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.